Coronavirus Latest News LIVE Updates: The cumulative number of COVID-19 vaccine doses administered in the country stands at 18,04,29,261 said the health ministry
With the death of 3,890 more COVID-19 patients, the total number of fatalities climbed to 2,66,207, said the health ministry on Saturday. This takes the national fatality rate to 1.09 percent.
The active COVID-19 caseload in India reached 36,73,802 on Saturday, comprising 15.07 percent of the total infections reported so far. India Saturday reported 3,26,098 fresh coronavirus cases, taking the overall count over 2.43 crore.
The cumulative number of COVID-19 vaccine doses administered in the country has crossed 18 crore, the Union health ministry said on Friday.
The ministry said 3,25,071 beneficiaries in the age group of 18-44 years received their first dose of COVID vaccine on Thursday and cumulatively 42,55,362 across 32 states and union territories since the start of the third phase of the vaccination drive.
The total of 18,04,29,261 include 96,27,199 healthcare workers (HCWs) who have taken the first dose and 66,21,675 HCWs who have taken the second dose, 1,43,63,754 frontline workers (FLWs) who have received the first dose, 81,48,757 FLWs who have taken the second dose, and 42,55,362 individuals in the 18-44 years age group who have received the first dose.
Besides, 5,67,99,389 and 87,50,224 beneficiaries aged over 45 to 60 years old have been administered the first and second dose, respectively, while 5,43,15,317 and 1,75,47,584 beneficiaries above 60 years have taken the first and second dose.
As on day-119 of the vaccination drive (14 May), total 10,79,759 vaccine doses were given.
A total of 6,16,781 beneficiaries were vaccinated for the first dose and 4,62,978 beneficiaries received the second dose of vaccine according to the provisional report till 8 pm, the ministry said, adding that the final reports would be completed for the day by late night.
The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level, it said.